<DOC>
	<DOCNO>NCT00112307</DOCNO>
	<brief_summary>The primary goal pilot study assess feasibility use magnetic resonance ( MR ) image guidance Magnetic Resonance Therapy ( MRT ) unit Brigham Women 's Hospital implantation brachytherapy applicator patient gynecologic malignancy . Patients gynecologic malignancy require brachytherapy currently treat either fluoroscopic CT visualization brachytherapy applicator . Magnetic resonance image show many study provide superior visualization cervix , vagina uterus compare CT . However prior study examine feasibility use real-time magnetic resonance image assist guidance gynecologic brachytherapy applicator</brief_summary>
	<brief_title>Magnetic Resonance Imaging Guided Gynecologic Brachytherapy</brief_title>
	<detailed_description>The primary endpoint involve ability MRT guide procedure protect bladder rectal tissue inadvertent insertion interstitial needle use deliver brachytherapy . MR image obtain MRT unit provide clear delineation bladder rectum allow great accuracy avoidance normal tissue upon interstitial needle insertion . CT image obtain follow insertion needle use MRT unit . The procedure consider failure CT imaging identifies insertion needle bladder rectum detect use MR . Secondary endpoint include ability MR image accurately reconstruct dosimetric plan construct dose volume histogram implantation interstitial needle well ability MR imaging accurately determine tumor , bladder rectal volume . Secondary endpoint also include assessment acute skin , genitourinary gastrointestinal toxicity well assessment tumor progression recurrence 180 day follow-up period .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<mesh_term>Vaginal Neoplasms</mesh_term>
	<criteria>Histologic documentation carcinoma . Carcinoma cervix : Stage IIIB , IVA vaginal recurrence Carcinoma cervix : Stage IB , IIA , IIB IIIA obliteration cervical o ( tandem ovoid implant feasible ) Carcinoma uterus : Stage IIIB ( vaginal involvement ) vaginal recurrence Carcinoma vagina : Stage II , III , IVA vaginal recurrence Carcinoma vulva : T3 ( vaginal extension ) T4 ( inoperable N stage ) , vaginal recurrence MRI CT pelvis within 2 month registration ECOG performance status &lt; 2 Age &gt; 18 Signed inform consent No metallic object pacemaker patient Negative pregnancy test childbearing potential Patients receive prior radiation chemotherapy may enrol study . Documented complete blood count ( CBC ) hematocrit ( Hct ) &gt; 30 , absolute neutrophil count ( ANC ) &gt; 500 , platelet ( Plt ) &gt; 40 Patients distant metastasis . Baseline study obtain . Patients pregnant lactate . Significant history cardiovascular disease .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>MRI</keyword>
	<keyword>Brachytherapy</keyword>
	<keyword>Carcinoma</keyword>
	<keyword>Cervix</keyword>
	<keyword>Uterus</keyword>
	<keyword>Vagina</keyword>
	<keyword>Vulva</keyword>
	<keyword>Carcinoma cervix</keyword>
	<keyword>Carcinoma uterus</keyword>
	<keyword>Carcinoma vagina</keyword>
	<keyword>Carcinoma vulva</keyword>
</DOC>